NasdaqGS - Nasdaq Real Time Price USD
Incyte Corporation (INCY)
61.16
+0.35
+(0.58%)
At close: May 14 at 4:00:02 PM EDT
64.00
+2.84
+(4.64%)
After hours: May 14 at 4:47:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 17 | 17 |
| Avg. Estimate | 1.39 | 1.53 | 5.82 | 6.68 |
| Low Estimate | 1.29 | 1.43 | 5.44 | 4.15 |
| High Estimate | 1.5 | 1.65 | 6.32 | 8.26 |
| Year Ago EPS | -1.82 | 1.07 | 1.08 | 5.82 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 16 | 22 | 20 |
| Avg. Estimate | 1.15B | 1.22B | 4.7B | 5.17B |
| Low Estimate | 1.13B | 1.18B | 4.58B | 4.83B |
| High Estimate | 1.19B | 1.27B | 4.82B | 5.51B |
| Year Ago Sales | 1.04B | 1.14B | 4.24B | 4.7B |
| Sales Growth (year/est) | 10.30% | 6.83% | 10.88% | 10.04% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 1.11 | 1.09 | 1.55 | 1.05 |
| EPS Actual | -1.82 | 1.07 | 1.43 | 1.16 |
| Difference | -2.93 | -0.02 | -0.12 | 0.11 |
| Surprise % | -264.53% | -2.03% | -8.01% | 10.62% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.39 | 1.53 | 5.82 | 6.68 |
| 7 Days Ago | 1.39 | 1.53 | 5.82 | 6.68 |
| 30 Days Ago | 1.47 | 1.58 | 5.82 | 6.69 |
| 60 Days Ago | 1.46 | 1.6 | 5.88 | 6.7 |
| 90 Days Ago | 1.46 | 1.6 | 5.83 | 6.72 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 1 | 3 | 4 |
| Up Last 30 Days | 3 | 1 | 4 | 5 |
| Down Last 7 Days | 7 | 9 | 11 | 7 |
| Down Last 30 Days | 7 | 8 | 10 | 8 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INCY | 176.59% | 42.95% | 439.33% | 14.71% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/30/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/30/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 4/21/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/24/2025 |
| Maintains | Truist Securities: Hold to Hold | 3/18/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 3/18/2025 |
Related Tickers
BMRN BioMarin Pharmaceutical Inc.
58.70
-1.81%
ALNY Alnylam Pharmaceuticals, Inc.
267.55
+0.26%
SNDX Syndax Pharmaceuticals, Inc.
9.28
-8.93%
IONS Ionis Pharmaceuticals, Inc.
32.60
+0.22%
RVMD Revolution Medicines, Inc.
39.48
-1.18%
INSM Insmed Incorporated
65.61
-0.15%
ACAD ACADIA Pharmaceuticals Inc.
17.16
-0.23%
GMAB Genmab A/S
19.08
-1.19%
EXEL Exelixis, Inc.
44.65
+20.84%
JAZZ Jazz Pharmaceuticals plc
106.59
+3.58%